Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Neurol Sci ; 305(1-2): 71-4, 2011 Jun 15.
Article in English | MEDLINE | ID: mdl-21440913

ABSTRACT

Loss of function mutations of the CACNA1A gene, coding for the α1A subunit of P/Q type voltage-gated calcium channel (Ca(V)2.1), are responsible for Episodic Ataxia type 2 (EA2), an autosomal dominant disorder. A dominant negative effect of the EA2 mutated protein, rather than a haploinsufficiency mechanism, has been hypothesised both for protein-truncating and missense mutations. We analysed the cacna1a mRNA expression in leaner mice carrying a cacna1a mutation leading to a premature stop codon. The results showed a very low mutant mRNA expression compared to the wild type allele. Although the mutant mRNA slightly increases with age, its low level is likely due to degradation by nonsense mediated decay, a quality control mechanism that selectively degrades mRNA harbouring premature stop codons. These data have implications for EA2 in humans, suggesting a haploinsufficiency mechanism at least for some of the CACNA1A mutations leading to a premature stop codon.


Subject(s)
Ataxia/genetics , Calcium Channels, P-Type/biosynthesis , Calcium Channels, P-Type/genetics , Calcium Channels, Q-Type/biosynthesis , Calcium Channels, Q-Type/genetics , Nystagmus, Pathologic/genetics , Animals , Animals, Newborn , Calcium Channels/genetics , Calcium Channels, N-Type , Calcium Channels, P-Type/physiology , Calcium Channels, Q-Type/physiology , Codon, Nonsense/genetics , Disease Models, Animal , Down-Regulation/genetics , Haploinsufficiency/genetics , Humans , Mice , Mice, Congenic , Mice, Inbred C57BL , Mice, Neurologic Mutants , Mutation, Missense/genetics , Weaning
2.
RNA ; 13(4): 555-62, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17283214

ABSTRACT

Carriers of premutation alleles (55-200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene have levels of FMR1 mRNA that are elevated by as much as 10-fold in peripheral blood leukocytes and CNS tissue. The excess expanded-repeat mRNA, per se, is now believed to result in forms of clinical involvement that are largely restricted to premutation carriers, including the neurodegenerative disorder, fragile X-associated tremor/ataxia syndrome (FXTAS). Although evidence to date suggests that the elevated mRNA is not due to increased stability, the basis for the increase is not known. In the current study, we have determined the relative transcriptional activities of premutation and normal FMR1 alleles using a highly sensitive nuclear run-on assay that involves immunocapture of digoxigenin-modified run-on transcripts followed by PCR amplification of the nascent transcripts. Using the nuclear run-on approach, we demonstrate that the rate of run-on synthesis of FMR1 transcripts is increased in premutation alleles. The current run-on assay should be broadly applicable to studies of other genes with promoters of weak to moderate strength. The fraction of capped FMR1 mRNA remains unaltered for premutation transcripts, indicating that elevated message levels are not due to premature escape from the cotranscriptional capping process. We also show that, in contrast to the situation with myotonic dystrophy, there is no net nuclear sequestration of premutation FMR1 mRNA. Finally, we have demonstrated that AGG interruptions within the CGG repeat element do not influence FMR1 mRNA levels.


Subject(s)
Fragile X Mental Retardation Protein/metabolism , Fragile X Syndrome/metabolism , Heterozygote , Nerve Tissue Proteins/metabolism , RNA, Messenger/metabolism , Transcription, Genetic , Alleles , Fragile X Mental Retardation Protein/genetics , Fragile X Syndrome/genetics , Leukocytes, Mononuclear/metabolism , Nerve Tissue Proteins/genetics , Nucleic Acid Amplification Techniques , Polymerase Chain Reaction , Trinucleotide Repeat Expansion/genetics
SELECTION OF CITATIONS
SEARCH DETAIL